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Abstract
Every cell has to undergo the cell cycle process before it can divide or differentiate. The
cell cycle is an error-prone complex process where mutations could happen. This study aimed to
characterize the nervous system and blood cells of the speed bump mutant in zebrafish. This
study also aimed to do gene characterization of the wee1 CRISPR mutant. The speed
bump mutant is due to a mutation in the wee1 gene. Lack of the wee1 gene will cause no Wee1
Kinase, which inhibits the MPF, causing cells to go into mitosis too early. To fulfill these
objectives, this study used in situ hybridization with neural probes and blood probes, antibody
staining, as well as sanger sequencing. It is found that, like other cell cycle mutants, neural cells
are differentiated in spbti279 mutants, but, unlike other cell cycle mutants, spbti279 mutants are
still able to make neuroblasts (stem cells that have decided to become neurons) even at the later
stages of development. It is also found that these spbti279 mutants do not produce red blood
cells. This study also found that the wee1 CRISPR mutants all have more severe phenotypes
compared to the spbti279 mutant and that frameshift mutations cause the wee1 CRISPR mutants
to lose the Wee1 protein kinase domain. In spbti279 mutants, the Wee1 protein kinase domain
still exists though it lost the last ten amino acids. These results indicate that the spbti279 mutants
are less likely to have a loss of function mutation and more likely to have hypomorph mutation.
The wee1 CRISPR mutants are likely to have a complete loss of function. The information
gathered in this study will allow a better understanding about the wee1 gene as well as the Wee1
Kinase domain during development.
.
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Introduction
All organisms in this world start from single living cells that undergo division to reproduce, such
as bacteria and yeast, or to create multicellular organisms such as metazoans. This process,
where cells divide, is tightly regulated and is known as the cell cycle. The cell cycle can be
broken down into four different phases: G1 (Gap 1), S (Synthesis), G2 (Gap 2), and M(Mitosis), as seen in Fig. 1. In G1, cells grow in size and synthesize cell organelles and proteins,
serving as the building block for division. G1 is also the phase where the cell may leave the cell
cycle. Next is the S-phase, where DNA is duplicated. During G2, an important checkpoint
includes wee1 to determine if DNA replication is complete; here, the cell also produces more
organelles and proteins to prepare for division. Cell division happens in the M-phase. Here, the
cell and its’ DNA are divided into two new daughter cells, segregating organelles and proteins
equally. If the newly divided cells do not enter another round of cell division, they next enter an
inactive state known as G0 instead of G1.

.
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Fig. 1 Overview of the cell cycle. The cell cycle is divided into four main phases: G1, S, G2,
and M. G0 is a phase in the cell cycle where cells rest. The complex Cyclin B and CDK1,
inhibited by Wee1, is also shown in this diagram to give an overview on how they affect the cell
cycle.
The cell cycle is a complicated process; therefore, damage may occur to either individual
cells or the organism as a whole when it goes wrong. In some cases, this causes cells to undergo
programmed death through a process known as apoptosis (Elmore, 2007), or a mutation is
introduced through the gain or loss of a chromosome (Levine & Holland, 2018). There are
checkpoints at each phase of the cell cycle to ensure everything goes well. These checkpoints are
composed of complexes made of a number of different cyclin proteins and cyclin-dependent
kinases. Together they perform specific biochemical functions (Malumbres, 2014).

Zebrafish have become a popular model organism as 70% of all human genes are found
in their genomes (Howe et al., 2013). Because zebrafish embryos are optically clear this has
allowed scientists to follow live development and the cell cycle under a microscope from the
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onset of fertilization (Kane & Kimmel, 1993). Furthermore, zebrafish lay many eggs (50-300)
that are fertilized externally, making it easier for researchers to manipulate their genes. For
example, one cell stage embryos can be easily injected with DNA or RNA to modify their
genetic makeup and because these eggs are born externally, the researcher does not have to harm
or kill the parents (D’Costa & Shepherd, 2009).
In the 1990s, a screen was carried out in Tübingen, Germany, by the Nusslein-Volhard
lab to identify mutations needed for the early development of the embryo. A category of mutants
was found in which embryos were arrested in the first 24 hours of development. This category
came to be known as the early arrest group. Embryos in this early arrest group were further
divided into two different groups: Class I and Class II. Class I mutants showed cellular
abnormalities before gross morphological defects arose in the embryo, while Class II mutants
exhibited gross morphological defects before cellular abnormalities appeared (Kane et al., 1996).
Included in the Class I mutants was speed bump (spbti279), named so due to its only normal
feature, the notochord causing the embryo to resemble a speed bump on the road.
The spbti279 mutant was one of the earliest mutants in the early arrest groups to express
a phenotype and was represented by a single recessive allele (Kane et al., 1996). Its phenotype
can be easily observed as early as 80% epiboly stage (8.5 hours post-fertilization) by a dark area
on either side of the midline that becomes more evident over time (Fig. 2A-D). spbti279 mutant
cells also appear to have difficulty with division (Kane et al., 1996). Since isolating the spbti279
mutant, the Kane lab mapped the spbti279 mutant to chromosome 18, near the vicinity
of wee1 (D. A. Kane, unpublished). wee1 is a good candidate gene for spbti279 because it plays
an important role in the cell cycle, and when wee1 is knocked out, it shows the same phenotype
as the spbti279 mutants. The Kane lab sequenced wee1 in the spbti279 mutant and found that a
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cytosine in exon 9 is changed into an adenine (R. M. Warga, Unpublished) (Fig. 2 E-F). This
converts a serine at position 524 into a stop codon and prematurely truncates the protein (R. M.
Warga, Unpublished). This premature termination could result in a null allele or loss of function
mutation in wee1. Nonsense mutations generally cause decay of the mRNA; therefore, no protein
can be translated (Smith, 2022). However, not all nonsense mutations result in loss of function,
in some cases, if the mutation is late in the gene, it leads to production of a truncated protein
(Smith, 2022). Studies by Emily Johnston in the Kane lab found that spbti279 mutants have
gradual depletion of wee1 mRNA but not complete loss of these transcripts (unpublished). For
this reason, Rachel Warga in the Kane lab, generated mutations in exon 2 of wee1 using
CRISPR/Cas9 mediated germline mutagenesis to create new alleles. CRISPR/Cas9 is a form of
gene-editing technology that allows scientists to make targeted double-stranded breaks in the
DNA. The CRISPR/Cas9 system consists of two main ingredients: the Cas9 enzyme that cuts
through DNA and makes a double-stranded break and a small RNA molecule, known as the
guide RNA that directs Cas9 to the specific sequence of DNA. Our DNA machinery will try to
fix the double-stranded break. Unfortunately, the process is error-prone and often introduces
mutations that can modify the genes (Arazoe & Mizutani, 2020). These wee1 CRISPR mutants
have a more severe phenotype and fail to complement the original spbti279 mutant allele (R. M.
Warga, unpublished). This indicates that the spbti279 mutant is truly a mutation in wee1, but that
it may not be a complete loss of function but rather a hypomorphic mutation, which is a mutation
that cause partial loss of gene function.
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Fig. 2 Overview of the spbti279 mutant A) A wild type zebrafish embryo developed
normally at 15 hours after fertilization. B) A wild type zebrafish embryo developed normally at
24 hours after fertilization. C) spbti279 mutant embryo at 15 hours after fertilization with dark
region around the neural keel and shorter length. D) spbti279 mutant at 24 hours after fertilization
with dark region throughout the embryos (Kane et al., 1996) E) Wee1 sequence data for wild
type zebrafish has serine a position 524. F) Wee1 sequence data for spbti279 mutant zebrafish has
a mutation where cytosine (C) is replaced with adenine (A) causing a serine to be changed to a
stop codon (R. M. Warga, unpublished).
wee1 is a gene first discovered in yeast by Paul Nurse in 1975 while working at the
University of Edinburgh in Scotland. Nurse found smaller colonies than typical yeast colonies,
hence the name wee1. Further study found that wee1 mutants have a shorter G2 phase (Nurse,
1975; Russell & Nurse, 1987). Eventually, Nurse and members of his lab found
that wee1 encodes a Kinase that regulates cell entry into mitosis by inhibiting the activity of the
Maturation Promoting Factor (MPF) (Murray, 2016).
The MPF is a complex composed of Cyclin-Dependent Kinase 1 (CDK1) and Cyclin B1
(Tyson & Novak, 2015). It is responsible for the breakdown of the nuclear envelope, stimulating
spindle formation, and condensation of the chromatin within the cell (Blow & Laskey, 1988;
Gautier et al., 1990; Labbé et al., 1989). MPF complex activity is also regulated by several other
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factors such as CDC25, a dual specificity phosphatase (Perry & Kornbluth, 2007), and the CDK
activation kinase (CAK). For cells to enter mitosis, the MPF must be activated (Fig. 3). First,
CAK phosphorylates the MPF at threonine 161 while at the same time, Wee1 inhibits this
activation by phosphorylating threonine 14 and tyrosine 15 on the MPF (Fesquet et al., 1993).
This complex regulation prevents a cell from entering mitosis too early, giving the cell enough
time to proofread all the DNA. Once the cell is ready to enter mitosis, CDC25 dephosphorylates
threonine 14 and tyrosine 15, releasing the inhibition placed on the MPF by Wee1 (Fig. 3) (Berry
& Gould, 1996; Den Haese, Walworth, Carr, & Gould, 2013). Thus CDC25 and Wee1 act in the
opposite, one as the gas and the other as the brake pedal on the MPF; dephosphorylation by
CDC25 actives the MPF, whereas phosphorylation by Wee1 inhibits the MPF. As a result,
a wee1 mutation will lack of inhibition on the MPF, and cells will go into mitosis too early
before DNA replication or DNA proofreading is complete (Perry & Kornbluth, 2007).

Fig. 3 MPF, CDC25, and Wee1 interaction. Active MPF is necessary for the cell to enter
mitosis. CAK will phosphorylate threonine 161 (T161) followed by Wee1 inhibiting the
activation of MPF by phosphorylating threonine 14 (T14) and tyrosine 15 (Y15), keeping cells
from entering mitosis prematurely. CDC25 dephosphorylates threonine 14 and tyrosine 15 to
active the MPF and allowing cell to enter mitosis. CDC25 and Wee1 acts as both gas pedal and
brake pedal respectively on MPF. The mutation on Wee1 will remove the brake pedal and will
result in continually active MPF thus cells entering mitosis prematurely (Figure from E.
Johnston, unpublished, 2019)
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Cell cycle mutants generally have problems with cell types that maintain actively
dividing cell populations, such as neural cells and blood cells. The Kane lab studies the cell cycle
and throughout the years has worked with a number of cell cycle mutants including: harpy, ogre,
and spectre (Riley et al., 2010; Warga et al., 2016; Petrachkova et al., 2019). These studies all
examined the development of various tissues and organs and found a general trend that the initial
patterning of the nervous system and blood is mostly normal, and only later differentiating cell
types are affected. This is because these are the cells that continue to divide. This motivates a
similar study with the spbti279 mutant.
Here, I characterize the development of the spbti279 mutant concentrating on the nervous
system and blood using in situ hybridization and antibody staining. Unlike all other cell cycle
mutants, there is no gradual reduction of the neuroblasts, which are neural stem cells progenitors.
spbti279 mutants appear able to constantly produce neuroblasts, even at later stages. In addition,
while spbti279 mutants produce endothelial cells, a cell type that shares a common lineage with
blood, spbti279 mutants have no red blood cells. I also characterized the development of the
CRISPR/Cas9 wee1 generated mutants made by targeting exon 2 on wee1, from here on referred
to as the wee1 CRISPR mutants, concentrating only on the nervous system. wee1 CRISPR
mutants have a far more severe phenotype compared to spbti279 , in that they have almost no
neural precursors. We also analysed the sequence data of several of the wee1 CRISPR mutants,
and based on their putative amino acid sequence, we show that all are missing the region
responsible for Wee1 kinase activity. From all the collected data, I conclude that the spbti279
mutant is not a true loss of function mutation and is more likely to be a hypomorph mutation
which is a partial gene mutation, while the wee1 CRISPR mutants are likely the true loss of
function mutation.
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2. Materials and Method
2.1 Zebrafish strains or Identification of Speed bump heterozygotes
The spbti279 mutants were outcrossed to wild-type strains to make heterozygote fish. For
this study, outcrossed fish were set up weekly to identify carriers of the genetically recessive
lethal mutation. Cells were collected, sorted, and cleaned. Then embryos were grown on E3
media (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2 2H2O, 0.33 mM MgSO4 7H2O) at 32C for
24 hours. After 24 hours, if spbti279 mutants embryos were identified from the crosses, the parent
fish were transferred to a new tank.
Trans-heterozygous fish stocks were made by crossing spbti279 with wee1 CRISPR
mutants. The embryos from these crosses were collected, sorted and cleaned. The embryos were
then grown on E3 media at 32C until it reached the right stage.
wee1 CRISPR mutants that we subjected to in situ hybridization were made by crossing
two different kinds wee1 CRISPR mutants (cr24xcr25, cr20xcr22, and cr50xcr22). The embryos
from these crosses were collected, sorted, and cleaned. The embryos were then grown on E3
media at 32C until it reached the right stage.

2.2 Embryos staging
Heterozygous fishes that were positively identified were crossed weekly to acquired wee1
CRISPR mutant embryos. Embryos were sorted, staged, and stored in E3 medium. By
manipulating the temperature, the growth speed of the embryos can be controlled. The embryos
were studied at these exact stages: tailbud, 4-somites, 5-somites, 8-somites, 12-somites, 16somites, 20-somites, and 24 hours.
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2.3 Embryo Fixation and Dechorionation
Embryos were fixed in 4% paraformaldehyde (4% PFA) in 1X Phosphate Buffer Saline
(PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 7H2O, 1.4 mM KH2PO4). Embryos
younger than 8-somites were fixed with intact chorions by placing them into a 2 mL Eppendorf
tube containing 1 mL of 4% paraformaldehyde in 1X PBS. Embryos older than 8-somites were
manually dechorionated first before placing them into a 2 mL Eppendorf tube containing 1 mL
of 4% PFA. Embryos were fixed overnight at 4C on a rocker. After the fixation period, embryos
that haven’t been dechorionated, were manually dechorionated on a small petri dish.
Dechorionated embryos were then washed four times with 1x Phosphate Buffered Saline with
Tween 20 (PBST; 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.76mM KH2PO4, 0.1%
Tween 20, pH 7.4) with the solution changed every 10 minutes. Embryos were then stored
methanol at -20C in 1.5 mL Eppendorf tube.

2.4 Whole mount In situ hybridization
Stored embryos were rehydrated with sequential 5 minute, 200 uL washes of three to one,
one to one, and one to three ratios of methanol to PBST solutions. Rehydrated embryos were
washed four times with PBST sequentially for 10 minutes before being digested with Proteinase
K (sigma) diluted in 1:1000 ratio. Figure 4 shows the times for which each stage was digested.
Stage of Embryo
Development
tailbud

Ratio of Proteinase K to
PBST
1:2000

Time Required for Digestion

4-somites

1:2000

2’

8-somites

1:1000

1’

12-somites

1:1000

2’

50”
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16-somites

1:1000

2’30”

20-somites

1:1000

3’

24 hours

1:1000

4’

Fig. 4 Digestion times for different stages of zebrafish. The figure illustrates the amount of
time each stage should be digested for desired results based on the data collected in the lab
Once the digestion is done, embryos were immediately refixed in 4% PFA for a
minimum of 1.5 hours at room temperature on a rocker. Once the second fixation was done,
embryos and solution handling were performed using gloves to reduce RNA contamination. The
embryos were washed five times with PBST for five minutes each on a rocker to remove the 4%
PFA completely. Embryos were then soaked in 200 uL prehybridization mixture (Hyb +; 60%
Formamide, 5X SSC, 50mM Heparin, 500mM t(torula)RNA, 0.1% Tween 20, 1M citric acid) for
two to five hours in a 70C water bath. Prehybridization mix was then changed and replaced with
200 uL of hybridization mixture containing antisense RNA probe (deltaA, Notch1b, gata1,
Pax2A, Islet1, tal1, and hbbe2) and held at 70C overnight.

RNA probes were taken out and restored the next morning. A quick wash in 200 uL
100% hybridization solution (Hyb -) was done as soon as the probes were taken out. Then the
embryos were sequentially washed with 200 uL of three to one, one to one, and one to three
ratios of hybridization solution to 2X saline sodium citrate (SSC; 0.3M NaCl, 30mM
Na3C6H5O7) for 15 minutes at 70C. Embryos were subjected to 15 minute washes with 2X
SSC at 70C before washing twice with 0.2X SSC for 30 minutes at 70C. After that, embryos
were removed from the water bath and wash sequentially with three to one, one to one, and one
to three ratios of 0.2X SSC to PBST for 10 minutes at room temperature. The embryos were then
washed with 100% PBST for 10 minutes at room temperature on a rocker. After that, the
15

embryos were put into a 1 mL block solution (PBST, 2% goat serum, 2mg/ml BSA) for a
minimum of two hours at room temperature. Block solution was then replaced and embryos were
incubated at 4C overnight on a rocker with anti-DIG diluted in 1 to 5000 ratio.

The next day, anti-DIG antibody was taken out and restored. Embryos were washed six
times for 15 minutes with 1X PBST at room temperature on a rocker. Embryos then were
washed in staining buffer (100mM Tris HCl pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween
20) for 5 minutes at room temperature before being washed in staining solution (solution buffer,
50 mg/mL NBT, 50 mg/mL BCIP) in the dark until staining became visible. Staining was
observed on a Nikon compound scope (MVI, Avon, MA). Once the staining was complete,
embryos were washed four times for 30 minutes in 1X PBST. Embryos were cleared in 70%
glycerol and stored in the dark at 4C (Thisse & Thisse, 2008)

2.5 Whole mount Antibody staining

Stored Embryos were rehydrated with sequential 5 minutes washes with three to one, one
to one, and one to three methanol to PBST. The embryos were washed for another 5 minutes in
100% PBST. Rehydrated embryos were then permeabilized in spot plates by washing for 5
minutes in dH2O then 5 minutes in ice cold acetone and lastly 2 to 3 minutes wash in dH2O.
Following the last wash, dH2O was replaced with PBST. Permeabilized embryos were then
incubated in AB block solution (PBST, 2% goat serum, 2mg/ml BSA) for a minimum of 2 hours
on a rocker at room temperature. Block solution was replaced with 1 antibody and the embryos
were incubated overnight at 4C on a rocker. The next day, primary antibody was saved and
stored and the embryos were subjected to four 30-60 minutes washes with PBST at room
temperature. PBST was then replaced with secondary antibody and the embryos were incubated
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overnight at 4C on a rocker. After the incubation period, the 2 antibody was stored and then
four 30-60 minutes washes with PBST were done with the embryos. After the PBST washes, the
embryos were washed three times for 10 minutes each with staining buffer (100mM Tris HCl pH
9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween 20). Staining buffer was then replaced with
staining solution (solution buffer, 50 mg/mL NBT, 50 mg/mL BCIP) and the embryos were
stained in the dark until staining became visible. Once the staining is complete, embryos were
wash four times for 30 minutes in 1X PBST before being cleared in 70% glycerol and stored in
the dark at 4C (Riley et al., 1999; Philips et al., 2006).

2.6 PCR and Gel Agarose

Five-somites embryos were manually dechorionated, placed into 96 PCR wells
containing 50 uL lysis buffer (10 mM Tris-HCl, pH8.3, 50 mM KCl, 1,5 mM MgCl2, 0.3%
Tween 20, 0.3% Triton X-100) and covered with PCR tape. The sample was incubated for 94C
for 20 minutes in a PCR machine before 5 uL of Proteinase K (Sigma) was added to every well.
Embryos were incubated again at 55C for 90 minutes and then denatured for 20 minutes at
94C. The products then were diluted to 1:20 ratio with ddH2O in a 200 uL new 96 well plate
and stored at -20C.

PCR solution was made by adding 5uL of the 1:20 dilution DNA Extract, PCR mix (10
mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.001% gelatin, 100 mM each dNTP, 100
mg/ml BSA). The PCR was carried out using 5 minute denaturation at 94C followed by 40
cycles of 94C denaturation for 30 seconds, followed by 45C of annealing for 30 seconds, and
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ended with 72C extension for 1 minute in PCR machine. The PCR reactions were then analyzed
using 1% agarose gel in 1X TBE buffer stained with ethidium bromide (EtBr).

2.7 Agarose Gel

Four grams of agarose powder was added to a 400 mL 1X TBE, then the solution was
boiled using a microwave in order to melt the agarose completely. When the gel cooled down,
3uL EtBr was added and swirled before pouring it into a gel tray with three 19 well combs. The
reservoir was filled with 1X TBE buffer and 8uL of EtBr was added throughout the reservoir.
Once the gel hardened, it was loaded into the reservoir. Loading dye was mixed with PCR
product before loading into the gel wells. 5 uL of 100 BP plus ladder was loaded into the wells as
reference. The gel was run for 180 volts for about 1 hour before being photographed under UV
light.

2.8 Photograph

Once the embryos were cleared, photographs were taken on a Nikon compound scope
(MVI, Avon, MA) for wild type and mutants at every stage.
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3. Results
3.1 spbti279 mutants do not undergo gradual depletion of neuroblasts
The nervous systems is a complex organ with many cell types, including an actively
dividing stem cell population whose function is to provide a constant source of cells that become
specified to a neural fate, leave the cell cycle, and differentiate. For this study, different kinds of
neural-specific genes including notch1b, deltaA, pax2A, and islet1 were used for in situ
hybridization, a method that visualizes the mRNA in the cells. Notch and Delta control neural
cell fate and proliferation in the nervous system. Notch is expressed in proliferating neural cells,
believed to be the stem cells (Bierkamp & Campos-Ortega, 1993). Its ligand, Delta, is briefly
expressed in newly specified neuroblasts or in newly post mitotic neurons, cells that have made
the decision to become neuron. The expression of Delta is transient as once the cell begins to
differentiate it turns off Delta (Appel & Eisen, 1998; Haddon et al., 1998). This study found that
in wild type embryos, notch1b gene expression is robust throughout the nervous system growing
stronger as the embryo gets older (Fig. 5A-E). Likewise, deltaA gene expression is constantly
high and robust in the wild type embryos at all stages (Fig. 6A-E, K) with neuroblasts constantly
being specified. In the spbti279 mutant, notch1b gene is still expressed in the nervous system
although its expression is somewhat delayed and severely reduced compared to the wild type
counterpart (Fig. 5F-J) and there were far fewer deltaA positive cells in the nervous system.
However, throughout all stages examined there was always a good amount of cells (Fig. 6F-J, L).
Thus although neural stem cells are severely depleted in spbti279 mutants, there appears to be a
continual supply of neuroblasts leaving the cell cycle even at later stages of development.
pax2A and islet1 are two post mitotic markers visualizing cells that have differentiated in
the nervous system. pax2A is expressed in cells in the midbrain-hindbrain border and in the
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spinal CoSA interneurons (Krauss et al., 1991). In wild type embryos, expression in the
midbrain-hindbrain boundaries as well as in the CoSA interneurons are very clear at all stages of
development (Fig.7 A-C). In spbti279 mutants, at the 12-somite stage in the spbti279 mutant, the
midbrain-hindbrain boundary looks almost normal however its expression decreases as embryos
get older (Fig7. D-F). Decreasing expression in the mutant midbrain-hindbrain boundary
suggests that this is not a differentiated cell population as a whole and that perhaps cells die as
they divide. Additionally, in spbti279 mutants, very few CoSA interneurons differentiate but their
number does not seem to change over time (Fig. 7 D-F)
islet1 is expressed in the trigeminal ganglion and primary neurons cells (Korzh et al.,
1993; Inoue et al., 1994). In wild type embryos, trigeminal ganglia expression is clearly seen
throughout all stages, starting from 4-somites (Fig. 8A-C). Primary motor neuron expression first
appears starting at 12-somites (Fig. 8C). In the spbti279 mutant embryos, both trigeminal ganglia
and primary motor neuron expression does not show up until the 12-somite stage (Fig. 8F).
Hence, both pax2A and islet1 suggest that neurons differentiate in spbti279 mutants, but their
number is not increased overtime even though neuroblasts continue to form.
Finally, I asked if these differentiated neurons ins spbti279 mutants are functional. The
anti-acetylated tubulin antibody labels mature neurons and their axons (Riley et al., 2010). At 24
hours in wild-type embryos, a vast number of neurons express anti-acetylated tubulin throughout
the nervous system including cells of the trigeminal ganglion (Fig. 9A). In spbti279 mutant
embryos, we found three different categories of expression: spbti279 mutants with a high number
of positive cells with axons (Fig. 9B; 6 embryos), spbti279 mutants with moderate amount of
positive cells (Fig. 9C; 3 embryos) and spbti279 mutants with almost no positive cells (data not
shown; 2 embryos). This indicates that even at older stages of development, some spbti279
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mutants have neural cells that survive quite well and are able to make axons. Thus like other cell
cycle mutants, spbti279 mutants can make some differentiated neurons. Because their number does
not appear to change over time, these for the most part do not die once they differentiate.
However, unlike other cell cycle mutants, such as ogre and specter, both neural stem cells and
neuroblast cells do not completely disappear over time in spbti279 mutants.
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smt

smt

ntc
ntc

Fig. 5 notch1b expression of neural cells in wild-type and spbti279 mutant embryos. A)
Notch 1B expression in wild type embryos at tailbud (10 hpf). B) Notch 1B expression in wild
type embryos at 4-somites (11.5 hpf). C) Notch 1B expression in wild type embryos at 8-somites
(13 hpf). D) Notch 1B expression in wild type embryos at 12-somites (15 hpf). E) Notch 1B
expression in wild type embryos at 16-somites (16 hpf). F) Notch 1B expression in spbti279
mutant embryos at tailbud (10 hpf). G) Notch 1B expression in spbti279 mutant embryos at 4somites (11.5 hpf). H) Notch 1B expression in spbti279 mutant embryos at 8-somites (13 hpf). I)
Notch 1B expression in spbti279 mutant embryos at 12-somites (15 hpf). Neural plate width
expression can be seen clearly (arrowheads) J) Notch 1B expression in spbti279 mutant embryos
at 16-somites (16 hpf). Neural plate width expression can be seen clearly (arrowheads). smt,
somatic; ntc, notochord; arrow heads, neural plate width
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Fig. 6 deltaA expression of neural cells in wild-type and spbti279 mutant embryos. A)
delta A expression in wild type embryos at tailbud (10 hpf). B) delta A expression in wild type
embryos at 4-somites (11.5 hpf). C) delta A expression in wild type embryos at 8-somites (13
hpf). D) delta A expression in wild type embryos at 12-somites (15 hpf). E) delta A expression in
wild type embryos at 16-somites (16 hpf). F) delta A expression in spbti279 mutant embryos at
tailbud (10 hpf). G) delta A expression in spbti279 mutant embryos at 4-somites (11.5 hpf). H)
delta A expression in spbti279 mutant embryos at 8-somites (13 hpf). I) delta A expression in
spbti279 mutant embryos at 12-somites (15 hpf). J) delta A expression in spbti279 mutant embryos
at 16-somites (16 hpf). K) delta A expression in wild type embryos at 24 hours. L) delta A
expression in spbti279 mutant at 24 hours.
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mhb

CoSA

D

mhb

E

mhb

CoSA
CoSA

F mhb

CoSA

Fig. 7 pax2A expression of neural cells in wild-type and spbti279 mutant embryos. A)
pax2A expression in wild type embryos at 12-somites (15 hpf). B) pax2A expression in wild type
embryos at 16-somites (16 hpf). C) pax2A expression in wild type embryos at 20-somites (17.5
hpf) D) pax2A expression in spbti279 mutant embryos at 12-somites (15 hpf). Neuron cells are
clearly visible (arrow) E) pax2A expression in spbti279 mutant embryos at 16-somites (16 hpf). F)
pax2A expression in spbti279 mutant embryos at 20-somites (17.5 hpf). mhb, midbrain-hindbrain;
CoSA, CoSA interneurons.
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WT

trg

trg
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D

E

F

spb
ti279
trg

pmn

islet1

4S

8S

12S

Fig. 8 islet1 expression of neural cells in wild-type and spbti279 mutant embryos. A)
isl1 expression in wild type embryos at 4-somites (11.5 hpf). B) isl1 expression in wild type
embryos at 8-somites (13 hpf). C) isl1expression in wild type embryos at 12-somites (15 hpf). D)
isl1expression in spbti279 mutant embryos at 4-somites (11.5 hpf). E) isl1expression in spbti279
mutant embryos at 8-somites (13 hpf). F) isl1expression in spbti279 mutant embryos at 12somites (15 hpf). trg, trigeminal ganglia; pmn, primary motor neuron
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trg

24h

24h

24h

Fig. 9 Anti-acetylated tubulin staining in wild-type and spbti279 mutant embryos. A)
acetylated tubulin staining in wild-type embryos at 24 hours post fertilization with trigeminal
ganglion clearly visible (arrow). B) Acetylated tubulin staining in spbti279 mutant embryos with
lots of mature axon expression at 24 hours. C) Acetylated tubulin staining in spbti279 mutant
embryos with fewer axon expression at 24 hours. trg; trigeminal ganglia
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3.2 spbti279 mutants do not produce red blood cells
Blood cells are another example where proliferation of less differentiated stem cells are
necessary. Blood cells have short life spans and once they fully differentiate, do not divide
(Cooper, 2000). This study used several kinds of blood specific genes: gata1 encodes a
transcription factor specific only to red blood cells (Brownlie et al., 2003), hbbe2 that encodes
hemoglobin, differentiated red blood cells (Detrich et al., 1995), and tal1 encodes a
transcriptional regulator for cells that become either blood or endothelium (Liao et al., 1998). In
wild-type embryos, robust expression from all probes can be observed (Fig. 10 A-E). Contrasting
that, red blood cell expression was undetectable in spbti279 mutants as neither gata1 nor hbbe2
expression was visible (Fig. 10 F-G). The lack of blood cell expression in spbti279 mutants
suggested that we look at more upstream markers. While wild type embryos have lots of blood
and endothelial progenitors, there were far fewer in spbti279 mutants (Fig. 10 C-E, H-J). It is
plausible that these cells expressing tal1 were either endothelial in nature or cells whose fate has
not been decided. Additionally, in spbti279 mutants tal1 expression is delayed which indicated by
more robust expression in 16-somites rather than at 8-somites or 12-somites (Fig. 10 H-J). Thus,
spbti279 mutants do not have red blood cells.
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gata1

16S hbbe2

16S tal1

8S
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16S

Fig. 10 Blood probes expression in wild-type and spbti279 mutant embryos. A) gata1
expression in wild type embryos at 16-somites (16 hpf). B) hbbe2 expression in wild type
embryos at 16-somites (16 hpf). C) tal1 expression in wild type embryos at 8-somites (13 hpf).
D) tal1 expression in wild type embryos at 12-somites (15 hpf). E) tal1 expression in wild type
embryos at 16-somites (16 hpf). F) gata1 expression in spbti279 mutant embryos at 16-somites
(16 hpf). G) hbbe2 expression in spbti279 mutant embryos at 16-somites (16 hpf). H) isl1
expression in spbti279 mutant embryos at 8-somites (13 hpf). I) isl1 expression in spbti279 mutant
embryos at 8-somites (15 hpf). J) isl1 expression in spbti279 mutant embryos at 16-somites (16
hpf).
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3.3 wee1 CRIPSR mutants have a more severe phenotype compared to the spbti279 mutants
Because we have identified new alleles of speed bump generated by targeting exon 2 of
wee1 using CRISPR/Cas9 we examined its phenotype as well. This was done by crossing two
different alleles of CRISPR mutants to each other. Examination of the nervous system of these
wee1 CRISPR mutants revealed that neural cell expression was severely reduced in the wee1
CRISPR compared to spbti279 mutants as only very few or almost no cells were observed (Fig. 11
A-F, Fig. 12 A-F, Fig 13 A-C). In notch1b, at 4-somites, expression in the brain and spinal cord
of wee1 CRISPR mutant was almost similar to spbti279 mutants (Fig. 11B, C). by 12-somites, very
little expression remained in either area (Fig. 11E, F). In dla, at 4-somites and 12-somites, wee1
CRISPR mutants have far less dla expression compared to spbti279 mutants (Fig. 12 B-C, E-F).
Furthermore, wee1 CRISPR mutant had almost no cells in the midbrain-hindbrain boundary or in
CoSA interneurons as visualized with pax2A (Fig. 13C). This severe reduction of neural cell
types suggests that the newly generated wee1 CRISPR mutant is the true loss of function
mutation while the original spbti279 allele is likely a hypomorph mutation.
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A

WT B

spbti279 C
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4S
WT E

4S

wee1

4S

spbti279 F

wee1

ntc

notch1b 12S

12S

ntc

12S

Fig. 11 notch1b expression comparison in wee1 CRISPR mutant, wild-type, and spbti279
mutant embryos. A) notch1b expression in wee1 CRISPR mutant wild type embryos at 4somites (11.5 hpf). B) notch1b expression in spbti279 mutant embryos at 4-somites (11.5 hpf). C)
notch1b expression in wee1 CRISPR mutant embryos at 4-somites (11.5 hpf). D) notch1b
expression in wee1 CRISPR mutant wild type embryos at 12-somites (15 hpf). E) notch1b
expression in spbti279 mutant embryos at 12-somites (15 hpf). F) notch1b expression in wee1
CRISPR mutant embryos at 12-somites (15 hpf). ntc, notochord; arrowheads, neural plate width.
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WT E

4S

4S
wee1
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12S

spbti279 F

12S

12S

Fig. 12 deltaA expression comparison in wee1 CRISPR mutant, wild-type, and
spbti279 mutant embryos. A) dla expression in wee1 CRISPR mutant wild type embryos at 4somites (11.5 hpf). B) dla expression in spbti279 mutant embryos at 4-somites (11.5 hpf). C) dla
expression in wee1 CRISPR mutant embryos at 4-somites (11.5 hpf). D) dla expression in wee1
CRISPR mutant wild type embryos at 12-somites (15 hpf). E) dla expression in spbti279 mutant
embryos at 12-somites (15 hpf). F) dla expression in wee1 CRISPR mutant embryos at 12somites (15 hpf).
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Fig. 13 pax2A expression comparison in wee1 CRISPR mutant, wild-type, and
spbti279 mutant embryos. A) pax2A expression in wee1 CRISPR mutant wild type embryos at
12-somites (15 hpf). B) pax2A expression in spbti279 mutant embryos at 12-somites (15 hpf). C)
pax2A expression in wee1 CRISPR mutant embryos at 12-somites (15 hpf).
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3.4 Sequence analysis of the wee1 CRISPR mutant
To determine what type of mutations were generated by targeting exon 2 of wee1, I
assisted in gaining wee1 sequence data from these wee1 CRISPR mutants. Because we are
working with the original generation and each founder fish has its own unique mutation, we had
to cross a CRISPR mutant carrier to a spbti279 mutant carrier to create trans-heterozygous mutants
embryos. We then amplified the DNA around exon 2 of these mutant embryos by PCR and sent
them out to be sequenced. We then analyzed the chromatograms and decoded the CRISPR
sequence from the spbti279 sequence which we already knew (Fig. 14A). Here we found that there
is a 5 base deletion with 2 base mismatch, which cause it goes out of frame (Fig 14B). There was
one exception, we had already generated a F1 generation from wee1 Cr7, thus in this case we
were able to create homozygous wee1 Cr7 mutant from which we obtained sequence data that we
show in Fig. 14 C and its derived mutant sequence shown in Fig. 14D that is 7 nucleotides longer
due to insertions and deletions and goes out of frame. If we’re to translate the wild-type and
spbti279 mutant nucleic acid to protein, we will see protein kinase domain for Wee1 in both
embryos, with 10 amino acids being lost in the spbti279 mutants (Fig. 15A). In comparison, in all
cases of all the wee1 CRISPR mutant that we have sent for sequencing so far, the mutations
which start in target 2 of exon 2, cause a frame shift resulting in premature termination of the
gene product. Due to the frame shift, if encoded, none of these wee1 CRISPR mutants would
seem to have the protein kinase domain for Wee1 (Fig. 15B). It is notable that in all the wee1
CRISPR mutants there are no example where the sequence remains in frame after the mutation
site. We would expected these protein to be roughly 1/3 of full length, perhaps such mutants
have no phenotype.
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A spbti279

B

wee1Cr38

5’ AGGACGATGGGCTCGACGAGCCGGAG 3’
5’ AGGACGATGGGCTCGACG-----GAG 3’

C WT

D

WT
wee1 Cr38

C’ wee1Cr7

5’ TTATTGTCGAGGGCCAGGACGATGGGCTCGACGAGCCGGA 3’

WT

5’ TTATTGTCGAGGGCCAGGACGATGGGAGAGAGTCGGAGAGAGCCGGA 3’ wee1 Cr7

Fig. 14 wee1 CRISPR mutants sequence analysis A) Sequence chromatograms of spbti279 and
wee1 Cr38 trans heterozygote. B) Nucleic acid sequence comparison between wee1 wild-type
and wee1 Cr38 mutant. C) Sequence chromatographs of wee1 Cr7 wild type embryos. C’)
Sequence chromatograms of wee1 Cr7 mutant embryos which were shown to be longer due to
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insertion mutations. B) Wild type and mutant nucleic acid sequenced for wee1 cr7 mutant. Purple
highlight indicated target 2, red font indicated bases that get inserted, green font indicated bases
that get replaced/ mismatched. Blue font (-) indicated bases that get deleted.

A

WT:
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGSTSRR
VALFTNVDSTSKACLDGKRNQTPRVNINPFTPDSILVQSSTLQRNNRKRSHWNDSCGEDMDASDAEIEDELIPPSKRITMMENNMM
SRYASEFHELEKIGSGQFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHPHVVRYYSAWAEDDHMLIQNEY
CNGGTLSDVIAENNRRMHFLSELELKDLLLQVSRGLKYIHSTALVHMDIKPSNIFISRKPAASVEEFEDEEDGPTTNVVYKIGDLG
HVTTVTNPQVEEGDSRFLANEVLQEDYSNLKKADIFALALTVVSASGAEPLPTNGDKWHKIRQGILPHIPQVLSQEFLSLLKLMIH
PDPTRRPSTSELVRHPVLLTASRMSADQLRVELNAEKFKNALLQKELKKAQMAKAAAEERVLTTDRVLTRSTIQSSSRASRLIGKK
MNRSVSLTIY*
ti279:

A’ spb

MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGCSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGSTSRR
VALFTNVDSTSKACLDGKRNQTPRVNINPFTPDSILVQSSTLQRNNRKRSHWNDSCGEDMDASDAEIEDELIPPSKRITMMENNMM
SRYASEFHELEKNGSGQFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHPHVVRYYSAWAEDDHMLIQNEY
CNGGTLSDVIAENNRRMHFLSELELKDLLLQVSRGLKYIHSTALVHMDIKPSNIFISRKPAASVEEFEDEEDGPTTNVVYKIGDLG
HVTTVTNPQVEEGDSRFLANEVLQEDYSNLKKADIFALALTVVSASGAEPLPTNGDKWHKIRQGILPHIPQVLSQEFLSLLKLMIH
PDPTRRP*

B

wee1Cr7 mutant: 3 base replace/mismatch, 7 base insertion, 1 base replace/mismatch
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGESRRE
PESRPLYEC*
wee1Cr20 mutant: 25 base deletion
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTTSLRMLI
QRVKPVWTVNETRHPE*
wee1Cr22 mutant: 5 base deletion, 16 base insertion resulting in: 11 extra bases and 4 mismatches.
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGSTESL
EAGYSPSLRMLIQRVKPVWTVNETRHPE*
wee1Cr24 mutant: 5 base deletion, 10 base replace/mismatch
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGDSDSR
PLYEC*
wee1Cr25 mutant: 41 base deletion and 7 base insertion/mismatch
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGSDSRV
KPVWTVNETRHPE*
wee1Cr27 mutant: 14 base deletion, some mismatches follow
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MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGSRPLY
EC*
wee1Cr38 mutant: 5 base deletion
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTMGSTESR
PLYEC*
wee1Cr42 mutant: 50 base deletion causing abrupt truncation
MSFGAGRHGKSPNLKPVRQKLQFSTSDGEEDSIEDANNSTGAESGFTELDSPVPLRRSLEKRPEDLGNSSPLSRNRDDDESWDEEG
FGSPSRVKPAFYMKSSPSPRKSPPAYDSSPERSYIHDDMEGSSSPIPDCPDTPPHKTFRKLRLFDTPHTPKSLLSRARTM*

Fig. 15 Wild-type, spbti279 mutants, and wee1 CRISPR mutants amino acid sequence
analysis. A) spbti279 wild type amino acid sequences. A’) spbti279 mutant amino acid sequences.
B) Amino acids sequences for wee1 CRISPR mutant that have been sequenced so far. Purple
highlight indicated target 2; green highlight indicated protein kinase domain for Wee1; Blue
highlight indicated frameshift to frame +3; yellow highlight indicated frameshift mutation to
frame +2; asterisk (*) indicated stop codon.
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4. Discussion
This study aimed to characterize the development of the spb mutant which is believed to
be a mutation in the wee1 gene as well as to provide further analysis that the spbti279 mutant is
truly a mutation in wee1. This study compared development of the nervous system and blood
between the spbti279 mutant and the new wee1 CRISPR mutants. Furthermore, this study also
provided sequence analysis data to show that the new wee1 CRISPR mutants are indeed
mutations in exon 2 that all result in premature termination before the wee1 kinase domain.
Hence because this study shows spbti279 has a less severe phenotype than the wee1 CRISPR
mutants and because wee1 CRISPR mutants lack a kinase domain and the spbti279 mutants does
not, this study indicates that spbti279 mutants are not likely to be a true loss of wee1 function.

The spbti279 mutation likely retains some activity of Wee1 protein suggesting that is a hypomorph
mutation rather than a loss of function mutation
Like any other cell cycle mutant, stem cells and neural percussors cells would be depleted
gradually as spbti279 mutants embryos get older (Riley et al., 2010; Warga et al., 2016;
Petrachkova et al., 2019) and that neural cells differentiate and production of functioning axons
do not increase. However, unlike other cell cycle mutants, neuroblasts in spbti279 mutants keep
being produced even at later stages of development. For example, we can see that there are high
numbers of dla expressing cells even at 24 hours. It is unusual to see constant production of
neuroblasts while at the same time not seeing increases in the number of differentiated pax2A
and islet1 positive cells. A possible explanation for this is because as neuroblast divide, some of
them just die before differentiation due to the replication mistakes; therefore no pax2A or islet1
positive cells could be observed. Additionally, it is also unusual to see that even though there is a
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slight decrease on notch1b positive cell, dla positive cells remain high. Notch is associated with
proliferating stem cells that will keep stem cell pools while Delta is associated with neuroblasts
(Appel et al., 2001). It is possible that the reason why there is a decrease in notch1b positive cells
but high number of dla positive cells as spbti279 mutants get older, is because as neural stem cells
divide, there are too many replication mistakes which cause cells to die. Meanwhile, neuroblast
cells do not undergo as many divisions as neural stem cells therefore they exhibit less cell death.
Previous study by the Kane lab also found that there are a lot of cells that undergo apoptosis in
spbti279 mutants (E. Johnston E, unpublished; J. Kelly, unpublished). Naturally, as there are less
and less stem cells, we would expect to have less neuroblasts as they come from the same pool;
yet, this is not observed in spbti279 mutants. Another possible explanation is that the dla
expressing cells we see at later stages are the same cells we see at younger stages. This may be
possible if dla is not a transient marker as it is thought (Appel & Eisen, 1998). dla labels cells
that have decided to become neurons and once the cell differentiated it will turn off dla. If the
cells do not turn off dla even at later stages, this would explain why we found high number of
dla expressing cells. As to why spbti279 mutants are able to produce neuroblasts cells even at later
stage is likely because the protein kinase domain of the wee1 gene in spbti279 mutants embryos is
never completely obliterated. wee1 mRNA in situ data collected by the Kane lab showed that
even though wee1 mRNA undergo gradual depletion, wee1 mRNA was never completely gone in
spbti279 mutants (E. Johnston, unpublished). Based on the spbti279 mutant putative amino acid
sequence data (Fig. 15 A’), we can see that the Wee1 protein kinase only lacks the last 10 amino
acids due to a nonsense mutation. We speculate that this Wee1 protein kinase domain, can still
perform some or most of its function. This is also backed up by comparison between spbti279
mutant in situ hybridization with wee1 CRISPR mutants in situ hybridization data which showed
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that the wee1 CRISPR mutants have more severe phenotype compared to spbti279 mutants, This
would mean that the spbti279 mutant is likely a hypomorphic mutation.

spbti279 mutants do not produce red blood cells
Just like with the nervous system, I found that blood cells in spbti279 mutants undergo
gradual depletion, like other cell cycle mutants (Riley et al., 2010; Warga et al., 2016;
Petrachkova et al., 2019). This study found that in spbti279 mutants there are no gata1 and hbbe2
positive cells. Since we know that both gata1 and hbbe2 label red blood cells (Brownlie et al.,
2003; Detrich et al., 1995), we can infer that the spbti279 mutants do not produce red blood cells.
We do see some tal1 positive cells but since tal1 encodes for both endothelium cells and blood
cells (Liao et al., 1998), it is more likely that the positive cells that observed are endothelial cells.
One possible explanation to why spbti279 mutants do not produce blood cells is that because all
the stem cells prefer to become endothelial cells instead of blood cells due to shortening time of
both G1 and G2. We know that spbti279 mutants have shorter G2 phase. A study found that Wee1
can extend G1 phase by suppressing the activity of CDK1 and CDK2 (Moiseeva et al., 2019),
which mean that spbti279 mutants will have shorter G1 phase as well. Blood cells and stem cells
come from the same stem cell pool. A study had found that the duration of G1 phase could have
effect on cell fate determination and that a longer G1 phase could lead to formation of pancreatic
cells instead of liver cells or duct cells (Yang et al., 2021). With a shorter G2 and possibly G1
phase, cells from the stem cell pools might prefer to form endothelial cells instead of blood cells.
Another possible explanation why no red blood cells can be observed in spbti279 mutants is that
tal1 is expression is usually early while in spbti279 mutants, tal1 expression is so delayed that it
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may have changed cell fates from blood to endothelial instead. This would help explain why no
red blood cells can be observed in spbti279 mutants.

Wee1 CRISPR mutants is the true loss of function mutation.
In situ hybridization with neural markers indicate that wee1 CRISPR mutants have a
more severe phenotype compared to spbti279 mutants. In wee1 CRISPR mutants, there was very
little, or almost no neuroblasts produced at either early or late stages. Furthermore, analysis of
the sequenced wee1 CRISPR mutants show that thus far, all have lost the Wee1 protein kinase
domain due to frame shift mutations. Without a protein kinase domain Wee1would be unable to
perform its function which is to inhibit the MPF. Thus cells would go into mitosis too soon and
likely to have replication mistakes. Therefore, we argue that the wee1 CRISPR mutants are the
true loss of function mutation. The most common wee1 CRISPR mutation was a deletion,
however there were also insertion and mismatched mutation. Due to deletion, insertion, and
mismatches, frame shifts mutation occured which causes wee1 CRISPR mutants to terminate
before its Wee1 protein kinase domain. This likely explains its more severe phenotype.
Therefore, the wee1 CRISPR mutants are likely the true loss of function mutation and spbti279
mutants are hypomorph mutation.

Present and Future Studies
In the future, further in situ hybridization and antibody staining can be performed with
wee1 CRISPR mutation at different stages to gain more data. Since we are still unable to get
CRISPR homozygous mutants and had been working with trans-heterozygote, experiments with
CRISPR homozygous mutants should be performed to give more insight about wee1 CRISPR
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homozygotes. Furthermore, in situ hybridization with different kind of blood probes should also
be performed to see if spbti279 truly does not produce red blood cells.
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